本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Theriva Biologics

1.36
+0.03502.65%
盤後1.360.00000.00%17:47 EDT
成交量:1.24萬
成交額:1.62萬
市值:377.08萬
市盈率:-0.07
高:1.36
開:1.26
低:1.25
收:1.32
資料載入中...
2025/03/31

重要事件披露

Form 8-K - Current report
2025/03/21

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/07

重要事件披露

Form 8-K - Current report
2025/01/21

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/12/10

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/05

重要事件披露

Form 8-K - Current report
2024/11/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/01

重要事件披露

Form 8-K - Current report
2024/10/16

重要事件披露

Form 8-K - Current report
2024/10/03

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/03

重要事件披露

Form 8-K - Current report
2024/10/02

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/30

重要事件披露

Form 8-K - Current report
2024/09/23

SEC問詢函

Form CORRESP - Correspondence
2024/09/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/20

SEC問詢函

Form CORRESP - Correspondence